How much does the Lao version of tofacitinib cost?

The Lao version of Tofacitinib is a targeted drug used to treat conditions such as rheumatoid arthritis, psoriatic arthritis and Crohn's disease. Currently on the market, generic drugs of tofacitinib have begun to enter different countries, and the price is cheaper than the original drug.
The Lao version of tofacitinib is a generic drug produced by Lucius Pharmaceuticals. According to the market price, its common specification is 5mg*30 tablets per box, and the price is about more than 200 yuan. Compared with the original drug, this price is much cheaper and can provide patients with a more economical treatment option. Since the ingredients of the Lao version of tofacitinib are basically the same as those of the original drug, its efficacy and side effects are not significantly different from those of the original drug.

Compared with the domestic original drug, the price of the Lao version of tofacitinib is significantly lower. The common specifications of domestic original drugs are 10mg*30 tablets, and each box may be sold for several thousand yuan. Although the drug has been covered by medical insurance, patients still have to pay a higher out-of-pocket portion. The Lao version of tofacitinib has become an economical alternative for many patients through its lower price, especially in the generic market.

As tofacitinib is launched in many countries around the world, the Lao version of tofacitinib has become one of the more popular choices on the market. Compared with generic drugs of tofacitinib produced in other countries (such as Bangladesh, etc.), the price of the Lao version of tofacitinib is also highly competitive. The price of tofacitinib produced in Bangladesh is about 200 yuan, and each box is usually 10mg*30 tablets. Although the price is slightly lower, the quality and market awareness of the Lao version are gradually improving.
For patients, the Lao version of tofacitinib can be purchased through some online drug platforms or international drug purchasing channels. However, since the drug has not yet been officially launched in mainland China, patients should carefully choose reliable channels when purchasing the drug to ensure that the source of the drug is regular and safe. When purchasing, you should also pay attention to possible price differences caused by different channels, and try to choose a channel that is reasonably priced and can provide formal certificates.
Reference: https://www.xeljanz.com/